Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 1 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Biotechnology | 1 |
| COVID-19 | 1 |
| Citations (References) | 1 |
| Corporations | 1 |
| Drug Therapy | 1 |
| Foreign Countries | 1 |
| Immunization Programs | 1 |
| Medical Research | 1 |
| Pandemics | 1 |
| Pharmacology | 1 |
| Publications | 1 |
| More ▼ | |
Author
| Kamali, Ali Reza | 1 |
| Rezaei, Asma | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
| Higher Education | 1 |
| Postsecondary Education | 1 |
Audience
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkRezaei, Asma; Kamali, Ali Reza – Industry and Higher Education, 2022
Collaboration between industry and universities is a driving force for scientific and technological advancements. Due to the role of AstraZeneca (AZ), a British-Swedish multinational pharmaceutical and biotechnology company, in combatting the COVID-19 pandemic, an analysis of the collaboration between the company and universities in the UK is of…
Descriptors: School Business Relationship, Universities, Medical Research, Drug Therapy
